Maravai LifeSciences Holdings, Inc. stock is up 8.94% since 30 days ago. The next earnings date is Feb 21, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 December’s closed higher than November. In the last 3 Unusual Options Trades, there were 3 PUTs.
Maravai LifeSciences Holdings, Inc. provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics.